| |
original article |
Date |
Title |
Authors All Authors |
| 1 |
[GO] |
2025―Nov―28 |
Antiviral clinical trial design throughout the COVID pandemic: evolving endpoints and lessons learnt |
Beatrice Z. Sim, Andre C. Kalil, Cameron R. Wolfe |
| 2 |
[GO] |
2025―Sep―03 |
Hot topics in pediatric infectious diseases: vaccines, molecular diagnosis, and emerging challenges post COVID-19 |
Asunción Mejías |
| 3 |
[GO] |
2025―Aug―13 |
Long COVID in children and young people: then and now |
Anna Coughtrey, Snehal M. Pinto Pereira, Shamez Ladhani, Roz Shafran, Terence Stephenson |
| 4 |
[GO] |
2025―Aug―01 |
Data science for pediatric infectious disease: utilizing COVID-19 as a model |
Bennett J. Waxse, Suchitra Rao |
| 5 |
[GO] |
2025―Apr―01 |
Updates on the neurological manifestations of SARS-CoV-2 infection |
Ferron F. Ocampo, Kathryn B. Holroyd |
| 6 |
[GO] |
2024―Dec―20 |
Health inequalities in respiratory tract infections - beyond COVID-19 |
Marina Ulanova |
| 7 |
[GO] |
2024―Oct―24 |
Antiviral combination treatment strategies for SARS-CoV-2 infection in immunocompromised patients |
Chiara Sepulcri, Claudia Bartalucci, Malgorzata Mikulska |
| 8 |
[GO] |
2024―Aug―06 |
SARS-CoV-2 infection vs. vaccination during pregnancy: the placenta leads the way |
Leire Pérez-Latorre, Octavio Ramilo |
| 9 |
[GO] |
2023―Aug―22 |
Gastrointestinal involvement in post-acute Coronavirus disease (COVID)-19 syndrome |
Uday C. Ghoshal, Ujjala Ghoshal |
| 10 |
[GO] |
2023―Jun―01 |
Respiratory protection: what SARS-CoV-2 has taught us |
Mark Loeb |
| 11 |
[GO] |
2023―Apr―24 |
Human adenovirus lung disease: outbreaks, models of immune-response-driven acute lung injury and pandemic potential |
Jay R. Radke, James L. Cook |
| 12 |
[GO] |
2023―Mar―20 |
Endemic, epidemic and pandemic infections: the roles of natural and acquired herd immunity |
Dennis L. Stevens, Amy E. Bryant |
| 13 |
[GO] |
2023―Feb―02 |
Estimating the global impact of coronavirus disease 2019 on people living with HIV |
John Thornhill, Chloe Orkin, Muge Cevik |
| 14 |
[GO] |
2022―Nov―08 |
Epidemiology of Gram-negative bacteria during coronavirus disease 2019. What is the real pandemic? |
Adrian J. Brink, Guy Richards, Hafsah Tootla, Elizabeth Prentice |
| 15 |
[GO] |
2022―Sep―27 |
Risk stratification for selecting empiric antibiotherapy during and after COVID-19 |
Jean-Ralph Zahar, Jean-Francois Timsit |
| 16 |
[GO] |
2022―Sep―12 |
Long COVID in children and adolescents |
Terence Stephenson, Roz Shafran, Shamez N. Ladhani |
| 17 |
[GO] |
2022―Jul―18 |
Long and persistent COVID-19 in patients with hematologic malignancies: from bench to bedside |
Justin C. Laracy, Mini Kamboj, Santosha A. Vardhana |
| 18 |
[GO] |
2022―Jul―18 |
The implications of the COVID-19 pandemic for long term care facilities |
Muh-Yong Yen, Jonathan Schwartz, Po-Ren Hsueh |
| 19 |
[GO] |
2022―Jul―18 |
Navigating the unknown: the coronavirus disease 2019 pandemic and solid organ transplantation |
Kassem Safa, Camille N. Kotton |
| 20 |
[GO] |
2022―Jul―18 |
Prevention of SARS-CoV-2 and respiratory viral infections in healthcare settings: current and emerging concepts |
Chanu Rhee, Meghan A. Baker, Michael Klompas |
| 21 |
[GO] |
2022―Feb―07 |
Methicillin-resistant Staphylococcus aureus lung infection in coronavirus disease 2019 |
Matteo Bassetti, Laura Magnasco, Antonio Vena, Federica Portunato, Daniele Roberto Giacobbe |
| 22 |
[GO] |
2022―Jan―24 |
Skin manifestations in patients with coronavirus disease 2019 |
Matteo Bassetti, Cesare Massone, Antonio Vena, Silvia Dettori, Claudio Conforti, Daniele Roberto Giacobbe, Iris Zalaudek |
| 23 |
[GO] |
2022―Jan―19 |
How common is ventilator-associated pneumonia after coronavirus disease 2019? |
Paul-Henri Wicky, Camille d’Humières, Jean-François Timsit |
| 24 |
[GO] |
2022―Jan―04 |
Invasive aspergillosis in coronavirus disease 2019 |
Frederic Lamoth |
| 25 |
[GO] |
2021―Nov―23 |
The impact of coronavirus disease 2019 on people with HIV |
Julia del Amo, Asuncion Diaz, Rosa Polo |
| 26 |
[GO] |
2021―Nov―09 |
Severe acute respiratory syndrome coronavirus 2 infection in the stem cell transplant recipient - clinical spectrum and outcome |
Mario Fernández-Ruiz, José María Aguado |
| 27 |
[GO] |
2021―Nov―09 |
Diagnosis of invasive fungal disease in coronavirus disease 2019: approaches and pitfalls |
P. Lewis White |
| 28 |
[GO] |
2021―Aug―04 |
Policy and planning for large epidemics and pandemics - challenges and lessons learned from COVID-19 |
Ashley Sharp, Vageesh Jain, Yewande Alimi, Daniel G. Bausch |
| 29 |
[GO] |
2021―Aug―02 |
Global health security as it pertains to Zika, Ebola, and COVID-19 |
Jaspreet Pannu, Michele Barry |
| 30 |
[GO] |
2021―Jul―26 |
COVID-19 transmission and the safety of air travel during the pandemic |
Aisha N. Khatib, Sarah McGuinness, Annelies Wilder-Smith |
| 31 |
[GO] |
2021―Jul―26 |
Gastrointestinal manifestations of coronavirus disease 2019 |
Tejas Joshi, Aijaz Ahmed, George Cholankeril |
| 32 |
[GO] |
2021―Jul―16 |
How coronavirus disease will change the face of travel medicine |
Mary E. Wilson |
| 33 |
[GO] |
2021―Jul―15 |
Coronavirus disease 2019 in children |
Emily R. Levy, Jennifer Blumenthal, Kathleen Chiotos |
| 34 |
[GO] |
2021―Jun―15 |
Infection prevention measures in acute care settings based on severe acute respiratory syndrome coronavirus 2 transmission patterns and risk |
Christina F. Yen, Polly van den Berg, Dana E. Pepe |
| 35 |
[GO] |
2021―Jun―03 |
Coronavirus disease 2019 vaccination in transplant recipients |
Christiane S. Eberhardt, Elisa Balletto, Markus Cornberg, Malgorzata Mikulska |
| 36 |
[GO] |
2021―May―27 |
Predisposition of COVID-19 patients to secondary infections |
Madhuri M. Sopirala |
| 37 |
[GO] |
2021―May―19 |
MDRO transmission in acute hospitals during the COVID-19 pandemic |
Louisa Sun Jin, Dale Fisher |
| 38 |
[GO] |
2021―May―19 |
The front-line during the coronavirus disease 2019 pandemic |
Minji Kang, Trish M. Perl |
| 39 |
[GO] |
2021―Mar―26 |
Mucosal immunity to Severe acture respiratory syndrome coronavirus 2 infection |
Janeri Fröberg, Dimitri A. Diavatopoulos |
| 40 |
[GO] |
2021―Mar―26 |
Neurologic aspects of coronavirus disease of 2019 infection |
Catherine E. Hassett, Jennifer A. Frontera |
| 41 |
[GO] |
2021―Jan―25 |
Applying the lessons learned from coronavirus disease 2019 to improve pneumonia management |
Grant W. Waterer |
| 42 |
[GO] |
2020―Dec―14 |
Potential and demonstrated impacts of the COVID-19 pandemic on sexually transmissible infections |
Olaitan T. Ogunbodede, Iryna Zablotska-Manos, David A. Lewis |
| 43 |
[GO] |
2020―Oct―07 |
COVID-19 in children |
Alasdair P.S. Munro, Saul N. Faust |
